None
SEDAR Interim Financial Statements
OGI · Price
[
{
"companyName": "Organigram Global Inc.",
"reportingPeriodEnd": "2025-12-31",
"reportStatus": "Unaudited",
"auditorName": null,
"auditorKeyMatters": [],
"balanceSheet": {
"cash": 7576,
"shortTermInvestments": 805,
"restrictedCash": 54585,
"accountsAndOtherReceivables": 49941,
"biologicalAssets": 16490,
"inventories": 116221,
"prepaidExpensesAndDeposits": 10927,
"totalCurrentAssets": 256545,
"propertyPlantAndEquipment": 123482,
"intangibleAssets": 46743,
"goodwill": 52524,
"deferredChargesAndDeposits": 1974,
"otherFinancialAssets": 49405,
"totalAssets": 530673,
"accountsPayableAndAccruedLiabilities": 71079,
"derivativeLiabilitiesCurrent": 16705,
"otherLiabilitiesCurrent": 6267,
"totalCurrentLiabilities": 94051,
"derivativeLiabilitiesLongTerm": 4644,
"preferredShares": 55017,
"otherLongTermLiabilities": 7505,
"totalLiabilities": 161217,
"shareCapital": 921612,
"equityReserves": 36418,
"accumulatedOtherComprehensiveIncome": 184,
"accumulatedDeficit": -588758,
"totalShareholdersEquity": 369456,
"totalLiabilitiesAndEquity": 530673,
"cashPerShare": 0.0561,
"workingCapitalPerShare": 1.2028
},
"incomeStatement": {
"grossRevenue": 97298,
"exciseTaxes": -33760,
"netRevenue": 63538,
"costOfSales": 40021,
"grossMarginBeforeFairValueAdjustments": 23517,
"realizedFairValueOnInventoriesSoldAndOtherInventoryCharges": -16911,
"unrealizedGainOnChangesInFairValueOfBiologicalAssets": 16709,
"grossMargin": 23315,
"generalAndAdministrative": 14950,
"salesAndMarketing": 8991,
"researchAndDevelopment": 2084,
"shareBasedCompensation": 708,
"totalOperatingExpenses": 26733,
"lossFromOperations": -3418,
"investmentIncomeNetOfFinancingCosts": -93,
"acquisitionAndTransactionCosts": 1606,
"changeInFairValueOfContingentConsideration": -1809,
"changeInFairValueOfDerivativeLiabilitiesPreferredSharesAndOtherFinancialAssets": -24392,
"otherNonOperatingExpenseNet": 1301,
"netIncomeLoss": 19969,
"changeInFairValueOfInvestmentsAtFairValueThroughOtherComprehensiveIncomeLoss": -419,
"comprehensiveIncomeLoss": 19550,
"netEarningsLossPerCommonShareBasic": 0.148,
"netEarningsLossPerCommonShareDiluted": 0.146,
"weightedAverageSharesOutstanding": 135132.782
},
"cashFlowStatement": {
"netIncomeLoss": 19969,
"shareBasedCompensation": 770,
"depreciationAndAmortization": 4980,
"realizedFairValueOnInventoriesSoldAndOtherInventoryCharges": 16911,
"unrealizedGainOnChangesInFairValueOfBiologicalAssets": -16709,
"investmentIncomeNetOfFinancingCosts": -93,
"changeInFairValueOfContingentConsideration": -1809,
"changeInFairValueOfDerivativeLiabilitiesPreferredSharesAndOtherFinancialAssets": -24392,
"unrealizedForeignExchangeLossGain": 626,
"cashAndRestrictedCashProvidedByUsedInOperatingActivitiesBeforeWorkingCapitalChanges": 253,
"netChangeInAccountsAndOtherReceivablesBiologicalAssetsInventoriesPrepaidExpensesAndDeposits": 6649,
"netChangeInAccountsPayableAndAccruedLiabilitiesProvisionsAndOtherLiabilities": -22915,
"netCashAndRestrictedCashUsedInOperatingActivities": -16013,
"paymentOfLeaseLiabilitiesNetOfSubleaseReceipts": -441,
"paymentOfLongTermDebt": -15,
"stockOptionsExercised": 6,
"netCashUsedInFinancingActivities": -450,
"purchaseOfShortTermInvestments": -800,
"proceedsFromShortTermInvestments": 826,
"acquisitionOfSubsidiaryNetOfCashAcquired": null,
"investmentIncome": 244,
"otherFinancialAssets": -2510,
"purchaseOfPropertyPlantAndEquipment": -2104,
"purchaseOfIntangibleAssets": null,
"netCashUsedInInvestingActivities": -4344,
"effectOfForeignExchangeOnCash": -626,
"decreaseInCashAndRestrictedCash": -21433,
"cashAndRestrictedCashBeginningOfPeriod": 83594,
"cashAndRestrictedCashEndOfPeriod": 62161,
"restrictedCash": -54585,
"cashAsPresentedOnTheStatementOfFinancialPosition": 7576
},
"investmentsAndOtherAssets": [
{
"type": "Preferred shares",
"description": "Investment in Weekend Holdings Corp. (WHC)",
"ownershipPercentage": null,
"value": 5688,
"notes": "Fair value changes recognized in other comprehensive income (loss)."
},
{
"type": "Secured convertible loan",
"description": "Investment in Phylos Bioscience Inc. (Phylos)",
"ownershipPercentage": null,
"value": 12081,
"notes": "Amended agreement provides for additional advances up to US$3.0 million, total aggregate principal up to US$10.0 million."
},
{
"type": "Convertible loan",
"description": "Investment in Steady State LLC (d/b/a Open Book Extracts) (OBX)",
"ownershipPercentage": null,
"value": 3529,
"notes": "Fair value determined using binomial lattice model."
},
{
"type": "Convertible loan",
"description": "Investment in Sanity Group GmbH (Sanity Group)",
"ownershipPercentage": null,
"value": 24252,
"notes": "Fair value determined using binomial lattice model."
},
{
"type": "Common shares",
"description": "Investment in Sanity Group GmbH (Sanity Group)",
"ownershipPercentage": null,
"value": 3855,
"notes": "Fair value determined using option pricing model (backsolve approach)."
}
],
"shareStructure": {
"authorizedShares": null,
"issuedShares": 135132782,
"classesOfShares": ["Common Shares"],
"warrants": [
{
"number": null,
"exercisePrice": 3.65,
"expiryDate": null
}
],
"options": [
{
"number": 2231345,
"exercisePrice": 10.17,
"expiryDate": null
}
],
"rightsConvertibleInstruments": "Top-up Rights held by BAT, Preferred Shares, Secured Convertible Loan Agreement, convertible notes in OBX and Sanity Group."
},
"managementCompensation": {
"currency": "CAD",
"periods": {
"threeMonthsEndedDecember312025": {
"salariesAndBonus": 1377,
"shareBasedCompensation": 476,
"total": 1853
},
"threeMonthsEndedDecember312024": {
"salariesAndBonus": 1302,
"shareBasedCompensation": 775,
"total": 2077
}
},
"namedIndividuals": [],
"otherRelatedPartyTransactions": [
{
"counterparty": "BT DE Investments Inc. (BAT)",
"description": "Product development collaboration agreement expenses",
"amount": 675,
"period": "threeMonthsEndedDecember312025"
},
{
"counterparty": "BT DE Investments Inc. (BAT)",
"description": "Product development collaboration agreement expenses",
"amount": 418,
"period": "threeMonthsEndedDecember312024"
}
]
},
"subsequentEvents": []
}
]
More from Organigram Global Inc
May 14, 2026 · 08:45